Skip to main content
. 2020 Jun 24;142(28):12020–12026. doi: 10.1021/jacs.0c04527

Figure 3.

Figure 3

UCHL1 labeling with 1 or 2 exclusively at catalytic Cys90 in vitro and in intact cells. (a) LC-ESI demonstrating single UCHL1 covalent modification with 1 or 2. (b) HeLa cells lacking endogenous UCHL1, transfected to express UCHL1 wild-type (WT) or catalytic cysteine mutants (C90A and C90S); pulldown following treatment with 2 and AzTB functionalization confirms specific Cys90 labeling.